CORDIS
EU research results

CORDIS

English EN
Pathogen and Graphene

Pathogen and Graphene

Objective

Complications related to infectious diseases have significantly reduced, particularly in the developed countries, due to the availability and use of broad-range antibiotics and wide variety of antimicrobial agents. Excessive use of antibiotics and antimicrobial agents increased significantly the number of multi-drug resistant (MDR) bacteria. This has resulted in a serious threat to public health. The inexorable rise in the incidence of antibiotic resistance in bacterial pathogens, coupled with the low rate of emergence of new clinically useful antibiotics, has refocused attention on finding alternatives to overcome antimicrobial resistance. Novel strategies aiming to reduce the amount of antibiotics, but able to prevent and treat animal and human infections should be investigated, evidenced and approved. Among the various approaches, the use of graphene and its derivatives is currently considered a highly promising strategy to overcome microbial drug resistance.

In line with this interest in graphene by the European Commission through the graphene ‘flagship’ initiatives, we respond in this consortium by exploring the utility of novel graphene based nanocomposites for the management and better understanding of microbial infections. The anti-microbical potential of the novel graphene based nanomaterials, the possibility of using such structures for the development of non-invase therapies together with the understanding of the mechanism of action will be the main focal points of the proposed project entitled “PANG”, relating to Pathogen and Graphene.

We have gathered the essential elements, namely different academic institutions in Europe (France, Germany, and Sweden) and their associated countries (Ukraine) as well as two European companies (Graphenea-Spain and LSO Medical-France) and one company (RS RESEARCH) in one of the associated countries (Turkey). The proposed multidisciplinary project uniquely suits high-level interdisciplinary and cross-border training.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

UNIVERSITE DE LILLE

Address

42 Rue Paul Duez
59800 Lille

France

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 108 000

UNIVERSITE DES SCIENCES ET TECHNOLOGIES DE LILLE - LILLE I

Address

Cite Scientifique Batiment A3
59655 Villeneuve D'Ascq

France

Activity type

Higher or Secondary Education Establishments

Participants (7)

Sort alphabetically

Sort by EU Contribution

Expand all

RUHR-UNIVERSITAET BOCHUM

Germany

EU Contribution

€ 72 000

UNIVERSITATSKLINIKUM ERLANGEN

Germany

EU Contribution

€ 45 000

GOETEBORGS UNIVERSITET

Sweden

EU Contribution

€ 22 500

LVIVSKYI NATIONALNYI MEDYCHNYI UNIVERSYTET IMENI DANYLA HALYTSKOHO

Ukraine

EU Contribution

€ 76 500

GRAPHENEA SA

Spain

EU Contribution

€ 49 500

LSO MEDICAL

France

EU Contribution

€ 49 500

RS ARASTIRMA EGITIM DANISMANLIK ILAC SANAYI TICARET LIMITED SIRKETI

Turkey

EU Contribution

€ 157 500

Project information

Grant agreement ID: 690836

Status

Ongoing project

  • Start date

    1 January 2016

  • End date

    31 December 2019

Funded under:

H2020-EU.1.3.3.

  • Overall budget:

    € 580 500

  • EU contribution

    € 580 500

Coordinated by:

UNIVERSITE DE LILLE

France